Effective on trade date October 4, 2016, and pending all relevant CFTC regulatory review periods, this Advisory Notice will supersede CME Group Market Regulation Advisory Notice RA1311-5RR from June 27, 2014. It is being issued as a result of several changes to the text of Rule 538 (“Exchange for Related Positions”) and the associated regulatory guidance contained in this Advisory Notice. The text of amended Rule 538 begins on page 3 of this Advisory Notice.
Click HERE to view full advisory.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.